2017•The Lancet Infectious DiseasesRequires access
Population implications of the use of bedaquiline in people with extensively drug-resistant tuberculosis: are fears of resistance justified?
Amber Kunkel, Jennifer Furin, Ted Cohen
Open publisher page 10 citations
Abstract
This record does not include an abstract. Use the full-text link above if available.